Document is current
Any future updates will be listed below
-
Authors
Pálóczi, Krisztina http://orcid.org/0000-0001-7065-3582
Buzas, Edit I. http://orcid.org/0000-0002-3744-206X
Falus, András http://orcid.org/0000-0002-6843-6789
-
Funding
Funding for this research was provided by:
NKFIH (NKFIH, Hungary, NVKP_16-1-2016-0017, OTKA K120237, Hungarian Thematic Excellence Programme No. TKP2020-NKA-26)
Hungarian Government and European Commission (VEKOP-2.3.2-16-2016-000002, VEKOP-2.3.3-15-2017-00016)
European Commission (H2020-MSCA-ITN-2017-722148, No. 739593)
European Commission and Hungarian Government (No. 739593)
European Commission and the Hungarian Government (RRF-2.3.1-21-2022-00003)
Semmelweis University
- License Information
-
More Information
Article History
Received: 21 July 2022
Accepted: 3 March 2023
First Online: 25 April 2023
Declarations
:
: E.I.B. is a member of the Advisory Board of Sphere Gene Therapeutics Inc. (Boston, MA, USA) and ReNeuron—Cell and Gene Therapy (UK).
